Skip to content

Co-Diagnostics nabs U.S. patent covering COVID-19 test

August 20, 2020

The USPTO has issued a new patent to Co-Diagnostics (NASDAQ:CODX) covering its CoPrimer technology used in its COVID-19 test and other molecular assays. The patent, which builds on an earlier patent awarded in October 2018 covering certain applications of the CoPrimer molecule, applies to the physical structure of the molecule.

https://seekingalpha.com/news/3607357-co-diagnostics-nabs-u-s-patent-covering-covidminus-19-test

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: